As More Women Cite Ovarian Cancer In Talcum Powder Lawsuit Filings, FDA Accepts Investigational Drug For Treatment

November 01, 2016 – – TheProductLawyers.com reports on an article by HemOncToday concerning the acceptance of an application for a new drug designed to treat ovarian cancer.

According to the article, the FDA accepted an investigational new drug application for cantrixil, which is in development as an intraperitoneal therapy for patients with ovarian cancer. The phase one study is expected to begin this year. The drug could be used as a form of chemotherapy for cancers in the abdomen if approved, the article said.

As phases move forward with new developments in ovarian cancer treatment, women are continuing to file lawsuits claiming their ovarian cancer is a result of prolonged use talcum powder products, such as those manufactured by Johnson & Johnson. As scientists continue to study the disease, numerous studies over the course of 45 years have found that women who use baby powder as a feminine hygiene product are more likely to develop ovarian cancer while others have been inconclusive. Johnson & Johnson has maintained denial in these claims and has previously stated that there is no link between talcum powder and ovarian cancer. The company has never released a warning about the potential risks of its Johnson’s Baby Powder and Shower To Shower products.

Several plaintiffs have already been awarded millions of dollars in compensation and lawsuit numbers are continuing to grow. Most of the filed cases are pending in a Missouri federal court, while others have been filed in New Jersey, where Johnson & Johnson is headquartered.

Banville Law has many years of experience fighting large pharmaceutical companies who have put dangerous drugs and devices onto the market, foregoing public safety for corporate greed.

The firm is looking to assist those who believe they have been directly affected by the use of Johnson’s talcum powder. Affected individuals may be entitled to financial compensation and legal action. Banville Law is currently offering free consultations to individuals who qualify.

For more information, to schedule a consultation or to ask questions contact Banville Law at (888) 976-6742.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60013036